NCT06586476

Brief Summary

The goal of this clinical trial is to evaluate the effectiveness of nightly timed awakening in the treatment of nocturnal enuresis in children aged 6-17. The main questions it aims to:

  • Determine feasibility of nightly timed awakenings
  • Determine the role, if any, of comorbidities on resolution of enuresis
  • Determine incidence of daytime accidents
  • Obtain patient and parental satisfaction scores Researchers will compare a control group to treatment groups to see if there is any impact on nocturnal enuresis. Participants will be woken up by parents in the middle of the night to use the restroom. In addition, participants will receive 30 minute psychotherapy sessions using telehealth.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
7mo left

Started Oct 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress74%
Oct 2024Dec 2026

First Submitted

Initial submission to the registry

September 4, 2024

Completed
15 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
12 days until next milestone

Study Start

First participant enrolled

October 1, 2024

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

September 19, 2024

Status Verified

April 1, 2024

Enrollment Period

2 years

First QC Date

September 4, 2024

Last Update Submit

September 5, 2024

Conditions

Keywords

LiftingIncontinenceBedwetting

Outcome Measures

Primary Outcomes (1)

  • Mean number of wet nights reported in electronic survey weekly for 12-weeks

    All study participants will report bed wetting via redcap electronic survey 1x/week for a 12-week period.

    Baseline to 12-weeks

Secondary Outcomes (5)

  • Mean change from baseline in the number of wet nights/week reported in electronic survey

    Baseline to 12-weeks

  • Percentage of patients with increased number of wet nights at 24-week follow-up as reported in electronic survey.

    24-weeks post-intervention

  • Mean number of nights reported weekly in electronic survey with timed awakening for 12-week period for intervention arm.

    Baseline to 12-weeks

  • Mean number of daytime accidents/week at baseline, end of 12-weeks and 24-weeks follow-up.

    Baseline to 24-week follow-up

  • Mean satisfaction score obtained from patient and parental satisfaction questionnaire.

    Baseline to 12-weeks

Study Arms (2)

Control

NO INTERVENTION

Standard of care, which includes in-clinic urotherapy at evaluation and 30-minutes psychotherapy sessions (every 3 weeks).

Nightly Timed Awakening

EXPERIMENTAL

Control-arm therapy plus a nightly timed-awakening intervention.

Behavioral: Nightly Timed Awakening

Interventions

Patients in this arm will be awakened 1-hr after going to bed by their caregiver(s) to use the restroom and then returned to sleep. This awakening will occur every night.

Also known as: Lifting
Nightly Timed Awakening

Eligibility Criteria

Age6 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • aged 6-17
  • referred to the urology clinic for enuresis (Enuresis in our study is defined as nocturnal or diurnal enuresis (more than 1 bedwetting episode/week) for greater than 3 months)

You may not qualify if:

  • Diagnosis of enuresis with comorbid diagnosis of diabetes mellitus (type 1 and 2), diabetes insipidus, chronic kidney disease, polyuria and/or polydipsia
  • Structural urologic disease (evaluated via baseline imaging)
  • Diagnosis of neurodevelopmental delays or conditions (i.e. celebral palsy, autism spectrum disorder) that hinders inability to follow age-appropriate instructions
  • Not potty trained
  • Improved or resolved enuresis for patients recently evaluated (within the past 6 months)
  • Non-English speaking
  • Patients currently on any over-active-bladder (OAB) medications (b3- agonists, antichloingerics) or alpha blockers for urinary symptoms (i.e. alfuzosin, tamsulosion, etc) or anti-diurectic medications for urinary symptoms (i.e.: desmopression (DDAVP))
  • Patients currently using bed-wetting alarms
  • Patients and families who are actively seeing Pediatric Clinical Urologic Psychologist.
  • Inability or unwillingness of individual or legal guardian/representative to give written informed consent or participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Hospital Los Angeles

Los Angeles, California, 90027, United States

Location

MeSH Terms

Conditions

Nocturnal Enuresis

Interventions

Lifting

Condition Hierarchy (Ancestors)

EnuresisUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesBehavioral SymptomsBehaviorElimination DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Mechanical PhenomenaPhysical Phenomena

Study Officials

  • Evalynn Vasquez, MD

    Children's Hospital Los Angeles

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Christine Do, DrPH

CONTACT

Jonathan Olais

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Staff/USC Faculty CWR

Study Record Dates

First Submitted

September 4, 2024

First Posted

September 19, 2024

Study Start

October 1, 2024

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

September 19, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations